IMA Pharmaceuticals

Twenty years of formulation. One rule.

01

Why a gummy. Because the best dose is the one you actually take. Tablets get skipped. Powders get shelved. A gummy gets taken, every day, without a glass of water or a second thought. So we call it what it is: a dose form.

02

Why sugar-free, wherever the formula allows it. Not as a selling point. As proof. With no sugar to hide behind, flavour cannot cover a thin dose. It is how you know the dose came first.

03

Why pharmacists. Because someone has to read the evidence and write the number. Our formulas are written by pharmacists, the dose is set by what the evidence supports, and the label is tested, not assumed.

Where it is made

Formulated in London, Ontario, with an office in New York. Made in the United States in an FDA-registered facility. Sold in Saudi Arabia through Tamer, with Arabic and English on every pack.

Five moments

  1. 2006. Twenty years ago, the first formula.

  2. The rule is written: dose first, flavour second.

  3. Production moves to an FDA-registered facility in the USA.

  4. Nineteen formulas across eighteen health areas, all sugar-free or reduced-sugar.

  5. 2026. Six of them arrive in Saudi Arabia.

The six

IMA Melatonin gummies 1 mg, gelatin-free, 60-count bottle, front of pack

IMA Melatonin

1 mg. Half an hour before bed.

Dose by age on the pack